Hyperfine (HYPR) Net Equity Issued and Repurchased (2025 - 2026)
Hyperfine's (HYPR) quarterly Net Equity Issued and Repurchased came in at $824000.0 in Q1 2026, down 84.8% YoY from $5.4 million in Q1 2025, and up 68.85% on a QoQ basis from $488000.0 in Q4 2025.
Hyperfine (HYPR) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends
Hyperfine (HYPR) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $824000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 84.8% year-over-year to $824000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased climbed to $824000.0 in Q1 2026, from $488000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $5.4 million in Q1 2025 to a low of $488000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Hyperfine | 88.36 Mn | 43.60 Mn | 1.98 Mn | 10.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.84 Mn |
| Jun 30, 2026 | 10.84 Mn |
| Mar 31, 2026 | 824,000.00 |
| Mar 31, 2026 | 824,000.00 |
| Dec 31, 2025 | 488,000.00 |
| Dec 31, 2025 | 488,000.00 |
| Sep 30, 2025 | 2.12 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 725,000.00 |
| Jun 30, 2025 | 725,000.00 |
| Mar 31, 2025 | 5.42 Mn |
| Mar 31, 2025 | 5.42 Mn |